- Exchange: London
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
GlaxoSmithKline PLC
+ Add to WatchlistGSK:LN
1,736.500 GBp 5.500 0.32%As of 09:12:54 ET on 05/24/2013.
Snapshot for GlaxoSmithKline PLC (GSK)
| Open: | 1,743.500 | Day's Range: | 1,726.500 - 1,749.000 | Volume: | 1,993,370 |
|---|---|---|---|---|---|
| Previous Close: | 1,742.000 | 52wk Range: | 1,314.000 - 1,773.000 | 1-Yr Rtn: | +29.56% |
Key Statistics for GSK
| Current P/E Ratio (ttm) | 20.1998 |
|---|---|
| Estimated P/E(12/2013) | 14.8716 |
| Relative P/E vs. UKX | 1.2069 |
| Earnings Per Share (GBP) (ttm) | 0.8599 |
| Est. EPS (GBP) (12/2013) | 1.1680 |
| Est. PEG Ratio | 2.1631 |
| Market Cap (M GBP) | 85,596.83 |
| Shares Outstanding (M) | 4,927.85 |
| 30 Day Average Volume | 7,712,847 |
| Price/Book (mrq) | 11.2730 |
| Price/Sale (ttm) | 3.2260 |
| Dividend Indicated Gross Yield | 4.80% |
| Cash Dividend (GBp) | 18.0000 |
| Last Dividend | 05/08/2013 |
| 5 Year Dividend Growth | 6.79% |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GSK
Company Profile & Key Executives for GSK
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
| Andrew WittyChief Executive Officer | Simon P DingemansChief Financial Officer |
| David RedfernChief Strategy Officer | Moncef SlaouiChairman:R&D & Vaccines |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GSK News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page